Natalizumab treatment during pregnancy - effects on the neonatal immune system

Background: Pregnancies in women with severe relapsing-remitting multiple sclerosis treated with natalizumab constitute a major challenge, because withdrawal of the drug may cause relapses but continuation might have unknown effects on the infantile immune system. Aims of the study To identify the i...

Full description

Bibliographic Details

Main Authors:	Rudolph, Henriette (Author) , Weber, Claudia Ellen (Author) , Schroten, Horst (Author) , Tenenbaum, Tobias (Author)
Format:	Article (Journal)
Language:	English
Published:	2013
In:	Acta neurologica Scandinavica Year: 2012, Volume: 127, Issue: 1, Pages: e1-e4
ISSN:	1600-0404
DOI:	10.1111/ane.12004
Online Access:	Verlag, Volltext: http://dx.doi.org/10.1111/ane.12004 Verlag, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1111/ane.12004
Author Notes:	H. Schneider, C.E. Weber, K. Hellwig, H. Schroten, T. Tenenbaum